Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer

Jeffrey Maurice Peters, Dae J. Kim, Moses T. Bility, Michael G. Borland, Bokai Zhu, Frank J. Gonzalez

Research output: Contribution to journalArticle

Abstract

Considerable progress has been made during the past 20 years towards elucidating the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in skin cancer. In 1999, the original notion that PPARβ/δ was involved with epithelial cell function was postulated based on a correlation between PPARβ/δ expression and the induction of messenger RNAs encoding proteins that mediate terminal differentiation in keratinocytes. Subsequent studies definitively revealed that PPARβ/δ could induce terminal differentiation and inhibit proliferation of keratinocytes. Molecular mechanisms have since been discovered to explain how this nuclear receptor can be targeted for preventing and treating skin cancer. This includes the regulation of terminal differentiation, mitotic signaling, endoplasmic reticulum stress, and cellular senescence. Interestingly, the effects of activating PPARβ/δ can preferentially target keratinocytes with genetic mutations associated with skin cancer. This review provides the history and current understanding of how PPARβ/δ can be targeted for both nonmelanoma skin cancer and melanoma and postulates how future approaches that modulate PPARβ/δ signaling may be developed for the prevention and treatment of these diseases.

Original languageEnglish (US)
Pages (from-to)1612-1622
Number of pages11
JournalMolecular Carcinogenesis
Volume58
Issue number9
DOIs
StatePublished - Jan 1 2019

Fingerprint

Peroxisome Proliferator-Activated Receptors
Skin Neoplasms
Keratinocytes
Endoplasmic Reticulum Stress
Cell Aging
Cytoplasmic and Nuclear Receptors
Melanoma
History
Epithelial Cells
Messenger RNA
Mutation

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research

Cite this

Peters, Jeffrey Maurice ; Kim, Dae J. ; Bility, Moses T. ; Borland, Michael G. ; Zhu, Bokai ; Gonzalez, Frank J. / Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer. In: Molecular Carcinogenesis. 2019 ; Vol. 58, No. 9. pp. 1612-1622.
@article{a1976316d5d84400a646d1f1a03fb99a,
title = "Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer",
abstract = "Considerable progress has been made during the past 20 years towards elucidating the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in skin cancer. In 1999, the original notion that PPARβ/δ was involved with epithelial cell function was postulated based on a correlation between PPARβ/δ expression and the induction of messenger RNAs encoding proteins that mediate terminal differentiation in keratinocytes. Subsequent studies definitively revealed that PPARβ/δ could induce terminal differentiation and inhibit proliferation of keratinocytes. Molecular mechanisms have since been discovered to explain how this nuclear receptor can be targeted for preventing and treating skin cancer. This includes the regulation of terminal differentiation, mitotic signaling, endoplasmic reticulum stress, and cellular senescence. Interestingly, the effects of activating PPARβ/δ can preferentially target keratinocytes with genetic mutations associated with skin cancer. This review provides the history and current understanding of how PPARβ/δ can be targeted for both nonmelanoma skin cancer and melanoma and postulates how future approaches that modulate PPARβ/δ signaling may be developed for the prevention and treatment of these diseases.",
author = "Peters, {Jeffrey Maurice} and Kim, {Dae J.} and Bility, {Moses T.} and Borland, {Michael G.} and Bokai Zhu and Gonzalez, {Frank J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/mc.23033",
language = "English (US)",
volume = "58",
pages = "1612--1622",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "9",

}

Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer. / Peters, Jeffrey Maurice; Kim, Dae J.; Bility, Moses T.; Borland, Michael G.; Zhu, Bokai; Gonzalez, Frank J.

In: Molecular Carcinogenesis, Vol. 58, No. 9, 01.01.2019, p. 1612-1622.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer

AU - Peters, Jeffrey Maurice

AU - Kim, Dae J.

AU - Bility, Moses T.

AU - Borland, Michael G.

AU - Zhu, Bokai

AU - Gonzalez, Frank J.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Considerable progress has been made during the past 20 years towards elucidating the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in skin cancer. In 1999, the original notion that PPARβ/δ was involved with epithelial cell function was postulated based on a correlation between PPARβ/δ expression and the induction of messenger RNAs encoding proteins that mediate terminal differentiation in keratinocytes. Subsequent studies definitively revealed that PPARβ/δ could induce terminal differentiation and inhibit proliferation of keratinocytes. Molecular mechanisms have since been discovered to explain how this nuclear receptor can be targeted for preventing and treating skin cancer. This includes the regulation of terminal differentiation, mitotic signaling, endoplasmic reticulum stress, and cellular senescence. Interestingly, the effects of activating PPARβ/δ can preferentially target keratinocytes with genetic mutations associated with skin cancer. This review provides the history and current understanding of how PPARβ/δ can be targeted for both nonmelanoma skin cancer and melanoma and postulates how future approaches that modulate PPARβ/δ signaling may be developed for the prevention and treatment of these diseases.

AB - Considerable progress has been made during the past 20 years towards elucidating the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in skin cancer. In 1999, the original notion that PPARβ/δ was involved with epithelial cell function was postulated based on a correlation between PPARβ/δ expression and the induction of messenger RNAs encoding proteins that mediate terminal differentiation in keratinocytes. Subsequent studies definitively revealed that PPARβ/δ could induce terminal differentiation and inhibit proliferation of keratinocytes. Molecular mechanisms have since been discovered to explain how this nuclear receptor can be targeted for preventing and treating skin cancer. This includes the regulation of terminal differentiation, mitotic signaling, endoplasmic reticulum stress, and cellular senescence. Interestingly, the effects of activating PPARβ/δ can preferentially target keratinocytes with genetic mutations associated with skin cancer. This review provides the history and current understanding of how PPARβ/δ can be targeted for both nonmelanoma skin cancer and melanoma and postulates how future approaches that modulate PPARβ/δ signaling may be developed for the prevention and treatment of these diseases.

UR - http://www.scopus.com/inward/record.url?scp=85065405108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065405108&partnerID=8YFLogxK

U2 - 10.1002/mc.23033

DO - 10.1002/mc.23033

M3 - Article

C2 - 31062422

AN - SCOPUS:85065405108

VL - 58

SP - 1612

EP - 1622

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 9

ER -